Stiripentol in Dravet syndrome: results of a retrospective U.S. study. - Test2 - elhamkhani - TriplyDB

Stiripentol in Dravet syndrome: results of a retrospective U.S. study.

Stiripentol in Dravet syndrome: results of a retrospective U.S. study.

http://www.wikidata.org/entity/Q38121171

about

A Stability-Indicating HPLC-DAD Method for Determination of Stiripentol: Development, Validation, Kinetics, Structure Elucidation and Application to Commercial Dosage Form Pharmacotherapy for Dravet Syndrome.Audit of use of stiripentol in adults with Dravet syndrome The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters.Clinical management of epileptic encephalopathies of childhood and infancy.Childhood Electroclinical Syndromes: a diagnostic and therapeutic algorithm.Pharmacological considerations in the use of stiripentol for the treatment of epilepsy.Stiripentol and vigabatrin current roles in the treatment of epilepsy.Treatment of Dravet Syndrome.Stiripentol in the Management of Epilepsy.Stiripentol for the treatment of super-refractory status epilepticus.Metabolic Dysfunction and Oxidative Stress in Epilepsy.Epilepsy transition: challenges of caring for adults with childhood-onset seizures.Adult motor phenotype differentiates Dravet syndrome from Lennox-Gastaut syndrome and links SCN1A to early onset parkinsonian features.Benign and severe early-life seizures: a round in the first year of life.

P2860

Q34412668-FE8A4B31-9D3D-4D8C-911A-337F63211CBE Q35953476-815269C9-52DA-4FC5-B4A4-B6DCA688E73C Q37505426-B179A572-13EA-4408-B430-B28795ADB488 Q38195817-9AB5DDC2-9E53-42C6-BFB6-5FFA3B3906FB Q38213837-20D221EA-E4A4-4403-870A-F84E221BAE80 Q38237593-FCAE3210-65C1-4995-A1DA-97E2CE675276 Q38738877-9415F952-8C50-4418-8972-E7D1F0B2CF4E Q38757727-2D7A44BA-D308-463B-B078-8FE2DB491884 Q38855474-E0A5CA76-DB9E-483C-8663-4E87D8D260E3 Q39256887-BD80FFC1-6E60-444F-B7E0-7C659BEE8D66 Q41159617-706D27FF-FD8E-4323-A3A6-2771D231DB41 Q46265742-779228E0-5F4C-498D-AE24-7427FCFADF76 Q46938437-5312933B-E4E8-4EB8-9CC1-0B4228CE16EE Q48253368-E1AA7C4B-E608-435A-88D3-BE22B87F7C43 Q55294576-4BFE102D-F753-49D9-A11E-25C54240F010

P2860

Stiripentol in Dravet syndrome: results of a retrospective U.S. study.

http://www.wikidata.org/entity/Q38121171

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Stiripentol in Dravet syndrome: results of a retrospective U.S. study.

@en

type

label

Stiripentol in Dravet syndrome: results of a retrospective U.S. study.

@en

prefLabel

Stiripentol in Dravet syndrome: results of a retrospective U.S. study.

@en

P1433

Q38121171-63EBDFD8-B63D-43A5-9EFE-860D4350D2B7

P1476

Q38121171-FA8CE74E-29FE-4180-A718-384D6440E3F1

P2093

Q38121171-04FD471A-8038-495D-9E77-7BD0CE80DACA

Q38121171-1CB7F016-7AA7-456C-947B-5C3E259009D1

Q38121171-3965A44C-85DA-45AE-9F44-F04525E82C38

Q38121171-47A7D802-07F1-4E7A-99B6-491E4CB504AA

Q38121171-495BAAE4-DF53-4BE7-830C-B02D69F1BF60

Q38121171-4F747240-5967-4071-9A16-2FC85065823D

Q38121171-5179B46D-1E5F-4CA2-81E6-2C2D2FCE4A32

Q38121171-776E350D-CE65-458B-A242-BB8A57CC23C6

Q38121171-79F161CE-8216-47DE-838D-B41410260CD6

Q38121171-A04EB2B8-F84E-4DA4-96D0-E5E12A4CAFE5

P2860

Q38121171-03CDF023-FAA5-4971-97EB-D686A40B1EDA

Q38121171-05527E74-E47D-4C37-8DE9-4CC221CF2EC2

Q38121171-123AD3BA-A3FB-4C22-95BA-8B0FC66ECFC1

Q38121171-12AA88BE-1A40-4E96-B996-AF26EF1E67F4

Q38121171-265392F2-EE9F-419A-A426-78D84BACC79A

Q38121171-49EB41C2-E1C5-4279-9190-2B90C3C5525E

Q38121171-4A4E12A5-1142-4B5F-A946-6CB8B547C136

Q38121171-5C4C87E2-338F-435D-ADF8-8D9D7D860DEF

Q38121171-5D557E82-1F24-4BAF-8A56-185B103477D1

Q38121171-5DE70FB3-55ED-42B4-94D5-9F61584A85B8

P304

Q38121171-9BE9976E-06D7-4F9A-B23C-753DE8709507

P31

Q38121171-77249A2B-8B3F-4776-B515-CFE70C029880

P356

Q38121171-D252265C-F875-476E-B4C5-5B082AD64BF8

P433

Q38121171-FC811AA0-30E3-44C7-BB11-9CBC24D5314C

P478

Q38121171-812FB1D5-FF52-426F-9ACE-D7D657C0379C

P50

Q38121171-28361E63-0A68-4FD2-AFA3-D0C0965C9D10

Q38121171-DE567CE0-F833-46E7-B5ED-76138FCA7B5F

P577

Q38121171-7554A57C-F40B-4E7E-A0F9-D864B5E62380

P5875

Q38121171-AD403A34-6138-4D98-B8C1-EF43B54A27F2

P698

Q38121171-73B5BB5E-6929-43B4-A4B2-14BFEAC5C793

P356

P1433

P1476

Stiripentol in Dravet syndrome: results of a retrospective U.S. study

@en

P2093

Angel Hernandez

http://www.w3.org/2001/XMLSchema#string

David N Franz

http://www.w3.org/2001/XMLSchema#string

Elaine C Wirrell

http://www.w3.org/2001/XMLSchema#string

Harry Chugani

http://www.w3.org/2001/XMLSchema#string

Ignacio Valencia

http://www.w3.org/2001/XMLSchema#string

Joseph Sullivan

http://www.w3.org/2001/XMLSchema#string

Laurent Chancharme

http://www.w3.org/2001/XMLSchema#string

Linda Laux

http://www.w3.org/2001/XMLSchema#string

Lorie Hamiwka

http://www.w3.org/2001/XMLSchema#string

Marcio Sotero de Menezes

http://www.w3.org/2001/XMLSchema#string

P2860

The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulator

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels

The pharmacologic treatment of Dravet syndrome

Cognitive development in children with Dravet syndrome.

Dravet syndrome: the long-term outcome.

Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet.

Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome.

Interactions between modulators of the GABA(A) receptor: Stiripentol and benzodiazepines

Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)--a nationwide questionnaire survey in Japan.

P304

1595-1604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EPI.12303

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Mohamad A. Mikati

P577

2013-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249317729

http://www.w3.org/2001/XMLSchema#string

P698

23848835

http://www.w3.org/2001/XMLSchema#string